Agricultural Antibiotics Scrutinized

Recent studies have shown that isolates of Campylobacter jejuni bacteria, major culprits in food poisoning, are gaining resistance to fluoroquinolone antibiotics, currently the drugs of choice in treating the disorder. Therefore, makers of agricultural antibiotics will soon need to take antibiotic resistance into account as part of the approval process, says Sharon Thompson, associate director for veterinary medical and international affairs at the Food and Drug Administration (FDA). A requireme

Written byHarvey Black
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Recent studies have shown that isolates of Campylobacter jejuni bacteria, major culprits in food poisoning, are gaining resistance to fluoroquinolone antibiotics, currently the drugs of choice in treating the disorder. Therefore, makers of agricultural antibiotics will soon need to take antibiotic resistance into account as part of the approval process, says Sharon Thompson, associate director for veterinary medical and international affairs at the Food and Drug Administration (FDA). A requirement for studies of new agricultural drugs is one part of an over-all framework introduced two years ago by FDA's Center for Veterinary Medicine to deal with antibiotic resistance. Further developments will elucidate what kinds of studies are needed to address what one researcher calls a "hot issue."

Researchers from the Minnesota Department of Health reported a nearly 10-fold jump (from 1.3 percent to 10.2 percent) in the number of fluoroquinolone-resistant C. jejuni samples taken from people between 1992 and 1998.1 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies